Dr. Sue Griffin received her PhD in Physiology at the University of Rochester’s School of Medicine and Dentistry.

She is the Alexa and William T. Dillard Professor and Vice Chairman of Research at the Donald W. Reynolds Department of Geriatrics at the University of Arkansas for Medical Sciences.

Dr. Griffin is the Director of Research at the Geriatric Research Education and Clinical Center at the  Veteran Affairs Medical Centre, a part of the Central Arkansas Veterans Healthcare System and she is Editor-in-Chief of the Journal of Neuroinflammation.

Dr. Griffin’s research interests focus on the mechanisms involved in the progression of Alzheimer’s disease and other neurodegenerative conditions such as Parkinson’s disease, Down Syndrome, head trauma, and epilepsy.

Her research has led to  a significant breakthrough in the early detection and treatment of Alzheimer’s, and it has drawn nationwide acclaim for Dr. Griffin, the Donald W. Reynolds Institute on Aging and the University of Arkansas for Medical Sciences.

In 2016 Dr. Griffin received the Lifetime Achievement Award from the Alzheimer’s Association at its International Conference in Toronto.

Learning Points:

How might Dr. Griffin’s latest discovery help in determining future treatment for  Alzheimer’s Disease?

What do we know that can help prevent or slow the progression of Alzheimer’s?

What  is autophagy and how is that different in people with Alzheimer’s?

https://www.radiomaria.ca/the-health-hub/